BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Dec 12, 2011
 |  BC Week In Review  |  Company News  |  Deals

Dendreon, CPP Investment Board deal

Dendreon will sell its royalty interest in HCV drug Victrelis boceprevir to CPPIB's CPPIB Credit Investments Inc. subsidiary for $125 million in cash. In 3Q11, Dendreon received $2.9 million in...

Read the full 139 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >